Am J Transplant, Volume 20, Suppl 3 Archives - Page 130 of 223 - ATC Abstracts

2020 American Transplant Congress
Geographic Variation in Listing for Kidney Transplantation: A State-Level Assessment of Access among Patients with End-Stage Renal Disease in the United States
M. N. Mustian, H. Qu, D. Anderson, P. A. MacLennan, R. D. Reed, C. Kale, B. Orandi, B. A. Shelton, V. Kumar, M. Hanaway, J. E. Locke
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Barriers to deceased donor kidney transplantation (DDKT) exist, including referral for transplant and waitlist addition, which may vary regionally. The objective of this study…
2020 American Transplant Congress
Higher Body Mass Index Before Living Kidney Donation Can Increase Wound Infection after Hand-Assisted Laparoscopic Living Donor Nephrectomies
X. Benavides, M. Merzkani, R. T. Rogers, E. K. Tan, S. Thirunavukkarasu, B. H. Smith, A. D. Rule, M. Prieto, J. K. Heimbach, T. Taner, G. K. Chow, P. G. Dean, M. D. Stegall
Kidney Transplant, Mayo Clinic, Rochester, MN
*Purpose: According to the CDC (2015-2016), 71.6% of the adult population in the United States has a BMI equal or higher than 25kg/m2, and the…
2020 American Transplant Congress
Calcium Level-Dependence of the Adverse Effect of Tertiary Hyperparathyroidism on Graft Survival in Renal Transplant Recipients
M. Okada, T. Tomosugi, T. Hiramitsu, K. Futamura, A. Kanda, N. Goto, S. Narumi, T. Ichimori, Y. Watarai
Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan
*Purpose: Tertiary hyperparathyroidism (THPT) is a condition in which hyperparathyroidism persists after renal transplantation (RTx), and is a frequent complication. The aim of this retrospective…
2020 American Transplant Congress
Risk Factors of Focal Segmental Glomerulosclerosis Recurrence in Pediatric Kidney Transplant Recipients : Single Center Experience
C. T. Chung, H. Ko, H. Mo, H. Kim, A. Han, S. Min, J. Ha
Seoul National University, College of Medicine, Seoul, Korea, Republic of
*Purpose: Focal segmental glomerulosclerosis (FSGS) is one of the most common causes of end stage renal diseases (ESRD) in children. Many pediatric patients diagnosed with…
2020 American Transplant Congress
Reduced Dose of Mycophenolate Mofetil as Well as Preformed DSA Are Risk Factors Associated with the Development of Chronic Active Antibody Mediated Rejection after Kidney Transplantation: A Retrospective Case Control Study
K. Shinoda¹, H. Oguchi¹, K. Nishikawa¹, T. Yonekura¹, M. Muramatsu¹, T. Kawamura¹, Y. Hamasaki¹, T. Mikami², K. Sakai¹, S. Shishido¹
¹Toho University Faculty of Medicine, Tokyo, Japan, ²Pathology, Toho University Faculty of Medicine, Tokyo, Japan
*Purpose: The purpose of this study is to explore the risk factors associated with the development of chronic active antibody mediated rejection (CAAMR) after the…
2020 American Transplant Congress
Comparing Surgical and Urological Complications Over Time in Deceased Donor Kidney Transplantation
A. Mekhaimar, H. Maple, N. Mamode, R. H. Zakri, N. Kessaris
King's College London/Guy's and St Thomas' Hospital, London, United Kingdom
*Purpose: Despite advances in perioperative and post-transplant management over time, complications still occur following deceased donor (DD) kidney transplantation. This study aimed to determine the…
2020 American Transplant Congress
Discontinuation Rates in Multicenter Trials – Are They Driven by Attitudes or Facts?
B. Nashan¹, F. Braun², D. Dragun³, I. A. Hauser³, P. Schemmer², H. J. Schlitt², C. Sommerer³, B. Suwelack³, C. Schiedel⁴, I. Kroeger⁴, F. Thaiss³
¹Athena and Hephaistos, Study Group, Germany, ²Hephaistos, Study Group, Germany, ³Athena, Study Group, Germany, ⁴Novartis Pharma GmbH, Nürnberg, Germany
*Purpose: The ATHENA [NCT01843348] and Hephaistos [NCT01551212] trials were designed to compare everolimus [EVR] in combination with reduced tacrolimus [rTAC] or reduced cyclosporine A [rCyA]…
2020 American Transplant Congress
Patients in Donor Service Areas with Higher Median MELD at Transplant Have a Lower Probability of Liver Transplant Waitlist Activation
J. Merola¹, S. Noreen², D. Stewart², R. Batra¹, D. Haakinson¹, G. Gan³, Y. Deng³, S. Kulkarni¹
¹Yale School of Medicine, New Haven, CT, ²United Network of Organ Sharing, Richmond, VA, ³Yale Center for Analytical Sciences, Yale University, New Haven, CT
*Purpose: US allocation of hepatic allografts is prioritized based on medical need, however significant geographical disparities exist with median MELD at transplant across donor specific…
2020 American Transplant Congress
Liver Transplantation for Primary Liver Sarcoma in Children-The US Experience from the Scientific Registry for Transplant Recipients (1988-2018)
A. Amin, K. Soltys, S. Ranganathan, G. Bond, A. Khanna, A. Ganoza, Q. Sun, G. Mazariegos, R. Sindhi
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Primary liver sarcomas (PLS) are rare tumors and encompass subtypes with diverse histology and varying outcomes. These subtypes include embryonal sarcoma (ES), rhabdomyosarcoma (RMS),…
2020 American Transplant Congress
Risk Factors for Hepatic Artery Thrombosis: A Single Center Study with Multiple Surgeons
M. Fitzsimons¹, M. Bindal², J. Buggs³, D. Patino⁴, E. Rogers³, A. Kumar¹, A. Lu³
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Surgery, Tampa General Hospital, Tampa, FL, ⁴University of Tampa, Tampa, FL
*Purpose: Hepatic Artery Thrombosis (HAT) is an uncommon complication after liver transplant, but its occurrence can lead to significant and fatal outcomes. Our objective was…